Richard Danger
Technik-/Wissenschafts-/F&E-Leiter bei BioMAdvanced Diagnostics SAS
Ursprung des Netzwerks ersten Grades von Richard Danger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
BioMAdvanced Diagnostics SAS
 BioMAdvanced Diagnostics SAS Medical SpecialtiesHealth Technology BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation.
4
| Holding Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Richard Danger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Graduate Degree | |
| Fondation Centaure | Director/Board Member | ||
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal | |
| Société Française D Immunologie | Director/Board Member | ||
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Founder |
Statistik
International
| Frankreich | 7 |
| Vereinigte Staaten | 3 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
| Government | 2 |
Operativ
| Founder | 6 |
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Independent Dir/Board Member | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sophie Brouard | 8 |
| Jean-Michel Bouler | 2 |
| Frédéric Pette | 1 |
| Nicolas Bouler | 1 |
- Börse
- Insiders
- Richard Danger
- Unternehmensverbindungen
